FRMM - 180 Life Sciences Corp.
3
-0.290 -9.667%
Share volume: 386,156
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$3.29
-0.29
-0.09%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-12-2024 | 11-14-2024 | 05-15-2025 | 07-23-2025 | 11-14-2025 | |
| Total revenue | 1.023 M | 1.701 M | 105.090 K | 3.736 K | 3.811 K | 12.284 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Selling general and admin | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating income | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Ebit | -1.070 M | 11.532 K | -836.720 K | -2.369 M | -1.727 M | -212.310 M | |
| Pretax income | -1.070 M | 11.781 K | -836.720 K | -2.369 M | -1.727 M | -208.671 M | |
| -101.10% | -7,202.28% | 183.16% | -27.12% | 11,985.63% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.070 M | 11.781 K | -836.720 K | -2.369 M | -1.727 M | -216.742 M | |
| 101.10% | -7,202.28% | -183.16% | 27.12% | -12,453.08% |